Beam Therapeutics IncNASDAQ:BEAM
- LAST PRICE23.0800
- TODAY'S CHANGE (%)-0.4000 (-1.7036%)
- Bid / Lots22.7000/ 6
- Ask / Lots23.7500/ 60
- Open / Previous Close23.4400 / 23.4800
- Day Range
- 52 Week Range
- Volume596,674
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BEAM |
|---|---|---|
| 09:32 ET | 7169 | 22.945 |
| 09:34 ET | 4416 | 22.98 |
| 09:36 ET | 1705 | 22.84 |
| 09:38 ET | 1827 | 22.83 |
| 09:39 ET | 900 | 22.7 |
| 09:41 ET | 5166 | 22.75 |
| 09:43 ET | 5035 | 22.92 |
| 09:45 ET | 3693 | 22.9 |
| 09:48 ET | 1000 | 22.7721 |
| 09:50 ET | 933 | 22.74 |
| 09:52 ET | 1181 | 22.775 |
| 09:54 ET | 1004 | 22.685 |
| 09:56 ET | 2565 | 22.71 |
| 09:57 ET | 2454 | 22.95 |
| 09:59 ET | 7543 | 23.09 |
| 10:01 ET | 3433 | 22.79 |
| 10:03 ET | 2608 | 22.71 |
| 10:06 ET | 368 | 22.745 |
| 10:08 ET | 2325 | 22.75 |
| 10:10 ET | 854 | 22.7 |
| 10:12 ET | 1304 | 22.84 |
| 10:14 ET | 8436 | 22.76 |
| 10:15 ET | 1269 | 22.7 |
| 10:17 ET | 3297 | 22.695 |
| 10:19 ET | 1780 | 22.69 |
| 10:21 ET | 1474 | 22.7 |
| 10:24 ET | 1704 | 22.69 |
| 10:26 ET | 100 | 22.71 |
| 10:28 ET | 5439 | 22.7 |
| 10:30 ET | 700 | 22.7 |
| 10:32 ET | 2608 | 22.82 |
| 10:33 ET | 500 | 22.77 |
| 10:35 ET | 1200 | 22.79 |
| 10:37 ET | 2370 | 22.71 |
| 10:39 ET | 1125 | 22.74 |
| 10:42 ET | 501 | 22.79 |
| 10:44 ET | 1097 | 22.9 |
| 10:46 ET | 973 | 22.9 |
| 10:48 ET | 505 | 22.89 |
| 10:50 ET | 1742 | 22.91 |
| 10:51 ET | 100 | 22.935 |
| 10:53 ET | 5159 | 22.9 |
| 10:55 ET | 200 | 22.935 |
| 10:57 ET | 2624 | 22.92 |
| 11:00 ET | 300 | 22.9 |
| 11:02 ET | 550 | 22.77 |
| 11:04 ET | 1682 | 22.89 |
| 11:06 ET | 500 | 22.894 |
| 11:08 ET | 1705 | 22.8601 |
| 11:09 ET | 403 | 22.905 |
| 11:11 ET | 2582 | 22.89 |
| 11:13 ET | 500 | 22.95 |
| 11:15 ET | 600 | 22.949 |
| 11:18 ET | 200 | 22.95 |
| 11:20 ET | 596 | 22.925 |
| 11:22 ET | 1402 | 22.885 |
| 11:24 ET | 700 | 22.885 |
| 11:26 ET | 1537 | 22.86 |
| 11:27 ET | 1200 | 22.885 |
| 11:29 ET | 3341 | 22.8 |
| 11:31 ET | 100 | 22.81 |
| 11:33 ET | 400 | 22.825 |
| 11:36 ET | 11223 | 22.87 |
| 11:38 ET | 6233 | 22.8201 |
| 11:40 ET | 2500 | 22.81 |
| 11:42 ET | 300 | 22.81 |
| 11:44 ET | 1917 | 22.87 |
| 11:45 ET | 14801 | 22.8 |
| 11:47 ET | 1328 | 22.86 |
| 11:49 ET | 400 | 22.87 |
| 11:51 ET | 4962 | 22.84 |
| 11:54 ET | 400 | 22.825 |
| 11:56 ET | 500 | 22.805 |
| 11:58 ET | 1816 | 22.7 |
| 12:00 ET | 100 | 22.72 |
| 12:02 ET | 1406 | 22.695 |
| 12:03 ET | 350 | 22.7 |
| 12:05 ET | 1955 | 22.7 |
| 12:07 ET | 1791 | 22.71 |
| 12:09 ET | 100 | 22.68 |
| 12:12 ET | 700 | 22.68 |
| 12:14 ET | 1048 | 22.72 |
| 12:16 ET | 400 | 22.74 |
| 12:18 ET | 900 | 22.69 |
| 12:21 ET | 750 | 22.715 |
| 12:23 ET | 900 | 22.69 |
| 12:27 ET | 1175 | 22.695 |
| 12:30 ET | 1089 | 22.72 |
| 12:32 ET | 2401 | 22.68 |
| 12:34 ET | 341 | 22.72 |
| 12:36 ET | 400 | 22.71 |
| 12:38 ET | 457 | 22.72 |
| 12:39 ET | 300 | 22.74 |
| 12:41 ET | 1099 | 22.715 |
| 12:43 ET | 973 | 22.7 |
| 12:45 ET | 300 | 22.72 |
| 12:48 ET | 492 | 22.74 |
| 12:50 ET | 1100 | 22.74 |
| 12:52 ET | 100 | 22.71 |
| 12:56 ET | 100 | 22.725 |
| 12:57 ET | 530 | 22.71 |
| 12:59 ET | 1913 | 22.77 |
| 01:01 ET | 887 | 22.76 |
| 01:03 ET | 700 | 22.77 |
| 01:06 ET | 700 | 22.76 |
| 01:08 ET | 1837 | 22.72 |
| 01:10 ET | 200 | 22.72 |
| 01:12 ET | 200 | 22.73 |
| 01:14 ET | 447 | 22.74 |
| 01:15 ET | 300 | 22.745 |
| 01:17 ET | 3800 | 22.755 |
| 01:19 ET | 1400 | 22.77 |
| 01:21 ET | 200 | 22.75 |
| 01:24 ET | 500 | 22.75 |
| 01:26 ET | 550 | 22.79 |
| 01:28 ET | 300 | 22.83 |
| 01:30 ET | 300 | 22.81 |
| 01:32 ET | 602 | 22.78 |
| 01:33 ET | 293 | 22.78 |
| 01:35 ET | 200 | 22.77 |
| 01:37 ET | 938 | 22.78 |
| 01:39 ET | 1700 | 22.81 |
| 01:42 ET | 775 | 22.8 |
| 01:44 ET | 784 | 22.81 |
| 01:46 ET | 300 | 22.81 |
| 01:48 ET | 368 | 22.84 |
| 01:50 ET | 400 | 22.81 |
| 01:51 ET | 100 | 22.8 |
| 01:55 ET | 1116 | 22.84 |
| 01:57 ET | 1469 | 22.85 |
| 02:00 ET | 2800 | 22.86 |
| 02:02 ET | 400 | 22.84 |
| 02:04 ET | 100 | 22.83 |
| 02:06 ET | 1839 | 22.85 |
| 02:08 ET | 400 | 22.83 |
| 02:09 ET | 1191 | 22.7925 |
| 02:11 ET | 100 | 22.775 |
| 02:13 ET | 499 | 22.775 |
| 02:15 ET | 600 | 22.75 |
| 02:18 ET | 648 | 22.75 |
| 02:20 ET | 206 | 22.75 |
| 02:22 ET | 357 | 22.7528 |
| 02:24 ET | 550 | 22.7284 |
| 02:26 ET | 535 | 22.74 |
| 02:27 ET | 200 | 22.715 |
| 02:29 ET | 790 | 22.7 |
| 02:31 ET | 100 | 22.7 |
| 02:33 ET | 1004 | 22.72 |
| 02:36 ET | 2534 | 22.7 |
| 02:38 ET | 300 | 22.69 |
| 02:40 ET | 700 | 22.73 |
| 02:42 ET | 987 | 22.75 |
| 02:44 ET | 1027 | 22.77 |
| 02:45 ET | 3300 | 22.75 |
| 02:47 ET | 7929 | 22.765 |
| 02:49 ET | 400 | 22.77 |
| 02:51 ET | 1300 | 22.77 |
| 02:54 ET | 588 | 22.79 |
| 02:56 ET | 1100 | 22.77 |
| 02:58 ET | 2914 | 22.77 |
| 03:00 ET | 400 | 22.78 |
| 03:02 ET | 700 | 22.77 |
| 03:03 ET | 924 | 22.79 |
| 03:05 ET | 950 | 22.77 |
| 03:07 ET | 1077 | 22.8 |
| 03:09 ET | 1671 | 22.9 |
| 03:12 ET | 1469 | 22.85 |
| 03:14 ET | 723 | 22.8759 |
| 03:16 ET | 500 | 22.88 |
| 03:18 ET | 900 | 22.88 |
| 03:20 ET | 1291 | 22.905 |
| 03:21 ET | 2201 | 22.93 |
| 03:23 ET | 420 | 22.945 |
| 03:25 ET | 1401 | 22.93 |
| 03:27 ET | 300 | 22.95 |
| 03:30 ET | 418 | 22.94 |
| 03:32 ET | 559 | 22.941 |
| 03:34 ET | 2725 | 22.98 |
| 03:36 ET | 3031 | 22.98 |
| 03:38 ET | 1673 | 22.97 |
| 03:39 ET | 628 | 22.985 |
| 03:41 ET | 1794 | 23.04 |
| 03:43 ET | 2947 | 23.06 |
| 03:45 ET | 667 | 23.04 |
| 03:48 ET | 2613 | 23.07 |
| 03:50 ET | 1200 | 23.08 |
| 03:52 ET | 6599 | 23.14 |
| 03:54 ET | 5035 | 23.04 |
| 03:56 ET | 10263 | 23.12 |
| 03:57 ET | 12661 | 23.105 |
| 03:59 ET | 21570 | 23.08 |
Jun 26, 2024
Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD), from 6:30AM ET on Wednesday Jun 26, 2024 by Dow Jones
6:30AM ET on Wednesday Jun 26, 2024 by Dow Jones
Jun 14, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Beam Therapeutics Inc | 1.9B | -13.2x | --- |
Catalyst Pharmaceuticals Inc | 1.8B | 28.2x | --- |
Veracyte Inc | 1.6B | -23.0x | --- |
Galapagos NV | 1.7B | 49.7x | --- |
Genmab A/S | 16.8B | 21.2x | +22.71% |
Maravai LifeSciences Holdings Inc | 1.8B | -7.0x | --- |
Company Information
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Contact Information
- Headquarters
- 238 Main StreetCAMBRIDGE, MA, United States 02142
- Phone
- 857-327-8775
- Fax
- 302-655-5049
Executives
- President
- Giuseppe Ciaramella
- Chief Executive Officer, Director
- John Evans
- Chief Financial Officer, Treasurer
- Terry-Ann Burrell
- Chief Medical Officer
- Amy Simon
- Chief Legal Officer and Secretary
- Christine Bellon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $360.9M |
Shares Outstanding | 82.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.74 |
Book Value | $12.02 |
P/E Ratio | -13.2x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -50.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
